PMID- 23832486 OWN - NLM STAT- MEDLINE DCOM- 20140623 LR - 20211021 IS - 1559-1166 (Electronic) IS - 0895-8696 (Linking) VI - 51 IP - 3 DP - 2013 Nov TI - Diabetes impairs synaptic plasticity in the superior cervical ganglion: possible role for BDNF and oxidative stress. PG - 763-70 LID - 10.1007/s12031-013-0061-1 [doi] AB - The majority of diabetics develop serious disorders of the autonomic nervous system; however, there is no clear understanding on the causes of these complications. In this study, we examined the effect of streptozocin (STZ)-induced diabetes on activity-dependent synaptic plasticity, associated levels of brain-derived neurotrophic factor (BDNF) and antioxidant biomarkers in the rat sympathetic superior cervical ganglion. Diabetes (STZ-induced) was achieved by a single intraperitoneal injection of streptozocin (55 mg/kg).Compound action potentials were recorded from isolated ganglia before (basal) and after repetitive stimulation, or trains of paired pulses to express ganglionic long-term potentiation (gLTP) or long-term depression (gLTD). The input/output curves of ganglia from STZ-treated animals showed a marked rightward shift along most stimulus intensities, compared to those of ganglia from control animals, indicating impaired basal synaptic transmission in ganglia from STZ-induced diabetic animals. Repetitive stimulation induced robust gLTP and gLTD in ganglia isolated from control animals; the same protocols failed to induce gLTP or gLTD in ganglia from STZ-induced diabetic animals, indicating impairment of activity-dependent synaptic plasticity in these animals. Molecular analysis revealed significant reduction in the levels of BDNF and the ratio of glutathione/oxidized glutathione. Additionally, the activity of glutathione peroxidase, glutathione reductase, catalase, and the levels of thiobarbituric acid-reactive substances were increased in ganglia from STZ-treated animals. In conclusion, impaired basal synaptic transmission and synaptic plasticity are associated with reduced BDNF and altered oxidative stress biomarkers in the sympathetic ganglia from STZ-induced diabetic animals, suggesting a possible correlation of these factors with the manifestations of STZ-induced diabetes in the peripheral nervous system. FAU - Alzoubi, K H AU - Alzoubi KH AD - Faculty of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. FAU - Khabour, O F AU - Khabour OF FAU - Alhaidar, I A AU - Alhaidar IA FAU - Aleisa, A M AU - Aleisa AM FAU - Alkadhi, K A AU - Alkadhi KA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130706 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Brain-Derived Neurotrophic Factor) RN - GAN16C9B8O (Glutathione) SB - IM MH - Action Potentials MH - Animals MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Diabetes Mellitus, Experimental/*metabolism/physiopathology MH - Glutathione/metabolism MH - *Long-Term Potentiation MH - Male MH - *Oxidative Stress MH - Rats MH - Rats, Wistar MH - Superior Cervical Ganglion/*metabolism/physiopathology EDAT- 2013/07/09 06:00 MHDA- 2014/06/24 06:00 CRDT- 2013/07/09 06:00 PHST- 2013/05/20 00:00 [received] PHST- 2013/06/23 00:00 [accepted] PHST- 2013/07/09 06:00 [entrez] PHST- 2013/07/09 06:00 [pubmed] PHST- 2014/06/24 06:00 [medline] AID - 10.1007/s12031-013-0061-1 [doi] PST - ppublish SO - J Mol Neurosci. 2013 Nov;51(3):763-70. doi: 10.1007/s12031-013-0061-1. Epub 2013 Jul 6.